These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2506091)

  • 1. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Widén E; Franssila-Kallunki A; Ekstrand A; Saloranta C; Schalin C; Eriksson J
    Diabetologia; 1989 Aug; 32(8):599-605. PubMed ID: 2506091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.
    Marena S; Tagliaferro V; Montegrosso G; Pagano A; Scaglione L; Pagano G
    Diabete Metab; 1994; 20(1):15-9. PubMed ID: 8056129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
    Elkeles RS
    Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy.
    Groop L; Schalin C; Franssila-Kallunki A; Widén E; Ekstrand A; Eriksson J
    Am J Med; 1989 Aug; 87(2):183-90. PubMed ID: 2757059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes.
    Rains SG; Wilson GA; Richmond W; Elkeles RS
    Diabet Med; 1988 Oct; 5(7):653-8. PubMed ID: 2975549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
    Gutniak M; Karlander SG; Efendić S
    Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
    Boyd K; Boreham C; Andrews WJ; Hadden DR
    Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles.
    Hermann LS; Karlsson JE; Sjöstrand A
    Eur J Clin Pharmacol; 1991; 41(3):263-5. PubMed ID: 1748145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy.
    Leslie P; Jung RT; Isles TE; Baty J
    Clin Sci (Lond); 1987 Jul; 73(1):41-5. PubMed ID: 3301165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
    Vigneri R; Trischitta V; Italia S; Mazzarino S; Rabuazzo MA; Squatrito S
    Diabete Metab; 1991 May; 17(1 Pt 2):232-4. PubMed ID: 1936482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
    Widén EI; Eriksson JG; Groop LC
    Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy.
    Boyd K; Rogers C; Boreham C; Andrews WJ; Hadden DR
    Diabetes Res; 1992 Feb; 19(2):69-76. PubMed ID: 1286541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.